Intuitive Surgical ( (ISRG) ) has released its Q2 earnings. Here is a breakdown of the information Intuitive Surgical presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Intuitive Surgical, Inc., headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, known for its da Vinci surgical systems and Ion endoluminal system. In its latest earnings report, Intuitive Surgical announced a strong financial performance for the second quarter of 2025, with significant growth in revenue and net income compared to the same period in 2024. The company’s revenue for the quarter reached $2.44 billion, marking a 21% increase from the previous year, driven by a 17% rise in worldwide da Vinci procedures and an increase in the installed base of da Vinci systems. Intuitive Surgical’s net income also saw a substantial rise, with GAAP net income reaching $658 million, or $1.81 per diluted share, compared to $527 million, or $1.46 per diluted share, in the second quarter of 2024. The company placed 395 da Vinci surgical systems during the quarter, including 180 of the latest da Vinci 5 systems, reflecting strong customer adoption. Additionally, Intuitive Surgical achieved European certification for its da Vinci 5 system for various minimally invasive procedures and obtained regulatory clearance in Japan for its use in multiple surgical specialties. Looking ahead, Intuitive Surgical remains committed to advancing care and improving patient outcomes, with expectations of continued growth in da Vinci procedures and a focus on broadening access to care and reducing costs.